The Valley Desk

NCT07908979 · Interventional trial

Risk-Enabled Therapy After Initiating EV/Pembro for Bladder Cancer

Overall registry status Recruiting

Phase 2

Conditions Bladder Cancer, Muscle-Invasive Bladder Carcinoma, Muscle-invasive Bladder Urothelial Carcinoma, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov